Silverfin false false 30/06/2024 01/07/2023 30/06/2024 Dr A Olsen 20/06/2020 08 June 2025 The principal activity of the company continued to be that of specialist medical practice activities. 12687352 2024-06-30 12687352 bus:Director1 2024-06-30 12687352 2023-06-30 12687352 core:CurrentFinancialInstruments 2024-06-30 12687352 core:CurrentFinancialInstruments 2023-06-30 12687352 core:ShareCapital 2024-06-30 12687352 core:ShareCapital 2023-06-30 12687352 core:RetainedEarningsAccumulatedLosses 2024-06-30 12687352 core:RetainedEarningsAccumulatedLosses 2023-06-30 12687352 core:PlantMachinery 2023-06-30 12687352 core:OfficeEquipment 2023-06-30 12687352 core:ComputerEquipment 2023-06-30 12687352 core:PlantMachinery 2024-06-30 12687352 core:OfficeEquipment 2024-06-30 12687352 core:ComputerEquipment 2024-06-30 12687352 core:RemainingRelatedParties core:CurrentFinancialInstruments 2024-06-30 12687352 core:RemainingRelatedParties core:CurrentFinancialInstruments 2023-06-30 12687352 bus:OrdinaryShareClass1 2024-06-30 12687352 2023-07-01 2024-06-30 12687352 bus:FilletedAccounts 2023-07-01 2024-06-30 12687352 bus:SmallEntities 2023-07-01 2024-06-30 12687352 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 12687352 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 12687352 bus:Director1 2023-07-01 2024-06-30 12687352 core:PlantMachinery core:TopRangeValue 2023-07-01 2024-06-30 12687352 core:OfficeEquipment core:TopRangeValue 2023-07-01 2024-06-30 12687352 core:ComputerEquipment core:TopRangeValue 2023-07-01 2024-06-30 12687352 2022-07-01 2023-06-30 12687352 core:PlantMachinery 2023-07-01 2024-06-30 12687352 core:OfficeEquipment 2023-07-01 2024-06-30 12687352 core:ComputerEquipment 2023-07-01 2024-06-30 12687352 bus:OrdinaryShareClass1 2023-07-01 2024-06-30 12687352 bus:OrdinaryShareClass1 2022-07-01 2023-06-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 12687352 (England and Wales)

CHRYSOL VENTURES LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 30 JUNE 2024
PAGES FOR FILING WITH THE REGISTRAR

CHRYSOL VENTURES LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 30 JUNE 2024

Contents

CHRYSOL VENTURES LIMITED

COMPANY INFORMATION

FOR THE FINANCIAL YEAR ENDED 30 JUNE 2024
CHRYSOL VENTURES LIMITED

COMPANY INFORMATION (continued)

FOR THE FINANCIAL YEAR ENDED 30 JUNE 2024
DIRECTOR Dr A Olsen
REGISTERED OFFICE 264 Banbury Road
Oxford
OX2 7DY
United Kingdom
COMPANY NUMBER 12687352 (England and Wales)
ACCOUNTANT Shaw Gibbs Limited
264 Banbury Road
Oxford
OX2 7DY
CHRYSOL VENTURES LIMITED

BALANCE SHEET

AS AT 30 JUNE 2024
CHRYSOL VENTURES LIMITED

BALANCE SHEET (continued)

AS AT 30 JUNE 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 29,177 53,564
29,177 53,564
Current assets
Cash at bank and in hand 947,164 924,099
947,164 924,099
Creditors: amounts falling due within one year 4 ( 381,838) ( 411,648)
Net current assets 565,326 512,451
Total assets less current liabilities 594,503 566,015
Net assets 594,503 566,015
Capital and reserves
Called-up share capital 5 1 1
Profit and loss account 594,502 566,014
Total shareholder's funds 594,503 566,015

For the financial year ending 30 June 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Chrysol Ventures Limited (registered number: 12687352) were approved and authorised for issue by the Director on 08 June 2025. They were signed on its behalf by:

Dr A Olsen
Director
CHRYSOL VENTURES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 30 JUNE 2024
CHRYSOL VENTURES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 30 JUNE 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Chrysol Ventures Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 264 Banbury Road, Oxford, OX2 7DY, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Balance Sheet date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Balance Sheet date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery 4 years straight line
Office equipment 4 years straight line
Computer equipment 4 years straight line

Depreciation methods, useful lives and residual values are reviewed at each balance sheet date. The selection of these residual values and estimated lives requires the exercise of judgement. The directors are required to assess whether there is an indication of impairment to the carrying value of assets. In making that assessment, judgements are made in estimating value in use. The directors consider that the individual carrying values of assets are supportable by their value in use.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include trade and other debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including trade and other creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including the director 1 1

3. Tangible assets

Plant and machinery Office equipment Computer equipment Total
£ £ £ £
Cost
At 01 July 2023 41,440 2,006 54,100 97,546
At 30 June 2024 41,440 2,006 54,100 97,546
Accumulated depreciation
At 01 July 2023 2,590 817 40,575 43,982
Charge for the financial year 10,360 502 13,525 24,387
At 30 June 2024 12,950 1,319 54,100 68,369
Net book value
At 30 June 2024 28,490 687 0 29,177
At 30 June 2023 38,850 1,189 13,525 53,564

4. Creditors: amounts falling due within one year

2024 2023
£ £
Amounts owed to related parties 254,100 254,100
Amounts owed to director 4,867 8,349
Accruals 7,740 10,843
Taxation and social security 115,131 138,356
381,838 411,648

5. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
1 Ordinary share of £ 1.00 1 1

6. Related party transactions

Included within other creditors is £4,867 (2023: £8,349) owed to the director. This amount is interest free and repayable on demand.

Included within creditors is £254,100 (2023: £254,100) owed to Chrysanna Ventures Limited, a company in which Dr A Olsen is sole director and shareholder. This amount is interest free and repayable on demand.